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Background: Estimation of the risk of adverse long-term outcome is of paramount importance in the treatment of critical
limb ischemia (CLI).
Methods: We evaluated the accuracy of two specific risk score systems, the Finnvasc score and the modified Prevent III
(mPIII) score, in 1425 CLI patients who underwent unilateral, infrainguinal surgical (47.6%) or endovascular (52.4%)
revascularization. The receiver operating characteristic (ROC) curve analysis was used to estimate the predictive value of
these risk scoring methods.
Results: The area under the ROC curve of Finnvasc score for prediction of 30-day amputation was 0.609 (95% confidence
interval [CI] 0.549-0.677) and of mPIII score 0.533 (95% CI 0.457-0.609). The area under ROC curve of Finnvasc score
for prediction of 30-day amputation-free survival was 0.622 (95% CI 0.573-0.671) and of mPIII score 0.588 (95% CI
0.533-0.642). The area under the ROC curve of Finnvasc score for prediction of 1-year amputation-free survival was
0.630 (95% CI 0.597-0.663, P < .0001) and of mPIII score 0.634 (95% CI 0.600-0.667, P < .0001). Finnvasc score
predicted leg salvage (relative risk [RR] 1.431, 95% CI 1.319-1.551), survival (RR 1.233, 95% CI 1.116-1.363), and
amputation-free survival (RR 1.422, 95% CI 1.319-1.534). mPIII score also predicted leg salvage (RR 1.190, 95% CI
1.108-1.277), survival (RR 1.245, 95% CI 1.193-1.300), and amputation-free survival (RR 1.223, 95% CI 1.176-
1.272).
Conclusions: Finnvasc and modified PIII risk scoring methods predict long-term outcome of patients undergoing
infrainguinal revascularization for CLI. Finnvasc score seems to perform well also in predicting immediate postoperative
outcome. (J Vasc Surg 2010;52:1218-25.)Estimation of the risk of adverse postoperative out-
come is of paramount importance in surgery, as it may
guide the clinician in the decision-making process, allow
planning of resource utilization, enable comparison be-
tween different institutions or surgeons, and, last but not
least, provide the patient with her/his individual operative
risk. This applies particularly to patients with critical leg
ischemia (CLI) as the outcome of reconstructed as well as
unreconstructed CLI can be rather poor.1,2 Two recently
derived specific risk scoring methods have been shown to
reliably predict the 30-day3,4 and 1-year5,6 outcome of
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1218these patients after surgical revascularization. However, it is
unknown whether they may perform well also in estimating
the long-term outcome of patients undergoing endovascu-
lar surgery, and which one should be preferred for clinical
and research purposes. Finnvasc score is useful in predicting
immediate postoperative outcome,3,4 but its usefulness as a
predictor of long-term outcome has not been validated
earlier. The aim of this study was to evaluate the accuracy of
these two specific risk score systems in a series of patients
who underwent infrainguinal surgical and endovascular
revascularization for CLI.
MATERIAL AND METHODS
A total of 2054 patients with CLI underwent lower
limb revascularization in Helsinki University Central Hos-
pital from January 2000 to December 2007. Among them,
1883 patients underwent unilateral, infrainguinal revascu-
larization, and 1425 patients with complete data were
included in this study. Data were retrieved from a prospec-
tive vascular and endovascular database of our institution
(Husvasc). No attempt to replace missing values was made.
This study was approved by the Institutional Review Board
of Helsinki University Central Hospital.
Clinical characteristics, operative data (shown in the
Table), and immediate postoperative outcome data of these
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database and scrutinized retrospectively. Date and cause of
late death were retrieved from the Finnish national popu-
lation registry, Statistics Finland. Data on late major lower
amputation have been completed retrospectively from files
of the National Institute for Health and Welfare. Coronary
artery disease (CAD) was defined as previously docu-
mented myocardial infarction and/or ongoing angina pec-
toris or previous coronary bypass surgery or endovascular
coronary intervention. Preoperative estimated glomerular
filtration rate (eGFR) was calculated according to the mod-
ified Modification of Diet in Renal Disease study equa-
tion7,8: eGFR (mL/min/1.73 m2) 186 (serum creat-
inine [mg/dL])1.154  (age)0.203  0.742 (if the
subject is female)  1.212 (if the subject is black). Severity
of renal failure was classified according to the chronic
kidney disease (CKD) classification.9
Finnvasc score was derived from a series of 3925 pa-
tients who underwent infrainguinal surgical revasculariza-
tion for CLI and whose data were included in the nation-
wide Finnvasc registry.3 Diabetes, coronary artery disease,
Table. Clinical and operative characteristics of 1425
patients who underwent isolated infrainguinal
revascularization for critical leg ischemia
Variables No. (%)
Age (years) 73.4  11.4





Coronary artery disease 909 (63.8)
Cerebrovascular disease 277 (19.4)
Pulmonary disease 215 (15.1)
eGFR (mL/min/1.73 m2) 65.9  34.1
eGFR class 5 95 (6.7)
Indication for revascularization
Rest pain 302 (21.2)
Ulcer 905 (63.5)
Gangrene 218 (15.3)






Endovascular revascularization 747 (52.4)
Surgical revascularization 678 (47.6)










eGFR, Estimated glomerular filtration rate.foot gangrene, and urgent operation were independentpredictors of 30-day postoperative mortality and/or major
lower-limb amputation, and this risk scoring method was
developed by assigning 1 point each to these four risk
factors.
Prevent III (PIII) risk scoring method was derived
from a prospective, randomized study on the efficacy of
edifoligide in preventing autogenous vein graft failure in
1404 patients who underwent infrainguinal vein bypass
surgery for CLI.5 A modified version of the PIII score was
proposed by the same authors6 in which baseline hemato-
crit was not included due to a large proportion of missing
values. Points for calculation of modified PIII were as-
signed to each patient for the presence of dialysis (4 points),
tissue loss (3 points), age 75 years (2 points), and coro-
nary artery disease (1 point). The total sum of points was
converted score which places the patient in the low (score
3), medium (score 4-7), or high risk (score8) category.
We did not have the information of number of patients on
dialysis, and, therefore for calculation of the modified PIII
score, we categorized dialysis as CKD class 5 (eGFR 15
mL/min/1.73 m2) as it appropriately includes patients
with the most severe degree of renal failure.9
Outcome end points. Leg salvage, overall survival,
and amputation-free survival were the main outcome end
points in this study. In order to assess the accuracy of these
scoring methods in predicting intermediate outcome, we
tested them by the receiver operating characteristic (ROC)
curve in predicting 1-year amputation-free survival by ex-
cluding patients with follow-up shorter than 1 year.
Statistical analysis. Statistical analysis was performed
using SPSS statistical software version 15.0 (SPSS Inc,
Fig 1. Receiver operating characteristics curve of Finnvasc risk
and modified PIII scores in predicting 1-year amputation-free
survival.Chicago, Ill). Continuous data are reported as the mean
rviva
8% th
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standard errors (SEs) were estimated by the Kaplan-Meier
method. Comparisons between curves were assessed using
Fig 2. Kaplan-Meier estimates for (a) leg salvage, (b) su
Finnvasc risk score classes. Standard errors (SEs) were aMantel-Cox log rank test for significance. The ROC curveanalysis was used to estimate the predictive value of these
risk scoring methods in predicting 30-day and 1-year
amputation-free survival. ROC curve is a graphic plot of
l, and (c) amputation-free survival according to different
roughout the whole time period.sensitivity and specificity of a continuous variable in pre-
Con
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mortality, major amputation and mortality, and/or major
amputation. Cox regression analysis with the backward
selection was used to adjust these risk scores for anatomic
level of revascularization (ie, femoropopliteal, crural, and
pedal revascularization), and type of revascularization (ie,
surgical vs endovascular revascularization). A P value .05
was considered statistically significant.
RESULTS
The mean follow-up of this study was 2.4  2.2 years
(range, 0-7.9 years). Leg salvage rates at 30 days, 1 year, 3
years, and 5 years were 95.3%, 85.2%, 81.5%, and 78.2%,
respectively (SE0.016); survival rates were 95.1%, 74.7%,
57.5%, and 46.6%, respectively (SE 0.018); amputation-
free survival rates were 91.1%, 67.2%, 50.4%, and 39.9%,
respectively (SE 0.017).
The area under the ROC curve of Finnvasc score for
prediction of 30-day amputation was 0.609 (95% confi-
dence interval [CI] 0.549-0.677; P  .003) and of
modified PIII score was 0.533 (95% CI 0.457-0.609;
P  .37).
The area under the ROC curve of Finnvasc score for
prediction of 30-day amputation-free survival was 0.622
(95% CI 0.573-0.671; P  .0001) and of modified PIII
score was 0.588 (95% CI 0.533-0.642; P  .001).
The area under the ROC curve of Finnvasc score for
prediction of 1-year amputation-free survival was 0.630
Fig 2.(95% CI 0.597-0.663; P  .0001) and of modified PIIIscore was 0.634 (95% CI 0.600-0.667; P  .0001; Fig 1).
In patients who underwent isolated endovascular proce-
dure, the area under the ROC curve of Finnvasc score for
prediction of 1-year amputation-free survival was 0.627
(95% CI 0.584-0.671; P  .0001) and of modified PIII
score was 0.595 (95% CI 0.550-0.640; P  .0001). In
patients who underwent surgical revascularization, the area
under the ROC curve of Finnvasc score was 0.658 (95% CI
0.612-0.704; P  .0001) and of modified PIII score was
0.677 (95% CI 0.629-0.725; P  .0001).
Kaplan-Meier estimates of leg salvage, survival, and
amputation-free survival for Finnvasc score and modified
PIII score are shown in Figs 2 and 3. A total of 135 patients
entered 6-year interval at survival analysis and 112 patients
in amputation-free survival analysis. Both risk scores per-
formed well in predicting the main long-term outcome end
points.
Cox regression analysis showed that when adjusted for
anatomic level of revascularization (ie, femoropopliteal,
crural, and pedal revascularization), elective versus urgent/
emergent procedure, and type of revascularization (ie, sur-
gical vs endovascular revascularization), Finnvasc risk score
was independent predictor of leg salvage (P .001; relative
risk [RR] 1.322; 95% CI 1.122-1.558), survival (P 
.0001; RR 1.483; 95% CI 1.344-1.636), and amputation-
free survival (P .0001; RR 1.422; 95% CI 1.319-1.534).
Modified PIII risk score adjusted for the above mentioned
variables was independent predictor of leg salvage (P 
tinued.0001; RR 1.160; 95% CI 1.080-1.247), survival (P 
ere 
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free survival (P  .0001; RR 1.219; 95% CI 1.170-1.270)
as well.
DISCUSSION
During the last decades, a large amount of studies
Fig 3. Kaplan-Meier estimates for (a) leg salvage, (b) su
modified PIII risk score classes. Standard errors (SEs) whave assessed the outcome of revascularization proce-dure for lower limb ischemia and identified a number of
risk factors associated with poor outcome. It is evident
that the nature of failed lower limb revascularization is
largely multi-factorial. Some factors are technical (ie, sub-
optimal graft material10 and poor run-off status11) and
others are patient-related (ie, severe comorbidities so often
l, and (c) amputation-free survival according to different
9% throughout the whole time period.rvivaassociated with CLI). The severity of atherosclerosis involv-
Con
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related complications, such as ulcer and gangrene are major
determinants of outcome. Indeed, in a few cases, major
amputation is required despite a patent bypass graft because
of irreversible ischemic tissue changes and infection.12-13
Varu et al,14 in their recent review, even suggested conser-
vative treatment or primary amputation for CLI patients
older than 75 years. However, Biancari et al3 found that age
was not an independent predictor of postoperative death
and/or limb loss. Indeed, in our series, more than half of
the patients were older than 75 years of age, and they had a
large number of comorbidities. In addition to technical and
patient-related factors, referral pathway, multidisciplinary
approach, and activity of revascularization policy have cer-
tainly impacted the outcome.15-17 Inclusion of these nu-
merous risk factors into a risk scoring method would result
in a complicated score that would not be easy to use for
clinicians and otherwise not necessarily accurate. The
herein evaluated risk-score methods showed that, despite
being very simple and including easily retrievable variables,
they can be rather accurate and identify those patients with
markedly poor long-term outcome. Certainly the area un-
der the ROC curve for both risk scores in predicting 1-year
amputation-free survival are not optimal, and this suggests
the complex nature of late failures and the difficulties to
derive a specific CLI risk scoring method.
The main difference between these two risk scoring
methods is that modified PIII score includes renal failure
as one factor, whereas Finnvasc does not. Indeed, pa-
tients with renal failure and critical limb ischemia under-
Fig 3.going infrainguinal bypass have poorer postoperativesurvival and higher amputation rates.18-20 On the other
hand, Finnvasc score separates foot gangrene as one risk
factor, but in modified P III score, gangrene and ulcer
are considered as one equivalent factor. Yet, there are
data suggesting that gangrene is a stronger independent
risk factor for poor outcome than stable ulcer.21,22
As observed in this study, Finnvasc score was predictive
of the immediate postoperative outcome, whereas modified
PIII score was not quite so accurate, especially when leg
salvage was considered. Also in this case, the area under the
ROC curve of Finnvasc score was far from being optimal.
An explanation for this difference might be that Finnvasc
score emphasizes the presence of foot gangrene, and might
therefore be a more accurate predictor of immediate leg
salvage. Otherwise, both risk scores showed to performwell
in predicting late outcome (Figs 2 and 3).
From a clinical point of view, the most important
benefit of these scoring methods might be their ability to
help to identify the patients whose poor outcome estimates
would suggest conservative approach. The present results
show that Finnvasc score 4 andmodified PIII scores 8 to 10
are associated with particularly low expectancy of leg sal-
vage and survival. The amputation-free survival curve is
particularly steep in these patients as most of them died
and/or had a major amputation within 1 year after revas-
cularization. The number of such high-risk patients is
rather small (6.2% and 4.2%, respectively), and these risk
scoring methods may indicate when any revascularization
attempt in such cases could be contraindicated and a con-
servative strategy more appropriate. Furthermore, as no-
tinuedticed also in previous risk scoring studies, when trying to
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ative data in vascular surgical patients, it is easier to predict
the patients with good outcome.23,24 However, the pro-
portion of patients with extremely poor outcome has been
low as in our study, which may be a result of good preop-
erative patient selection.23
This validation study showed that both Finnvasc score
and modified PIII score perform rather well also in patients
undergoing endovascular procedures, even if they have
been derived from patients who underwent surgical revas-
cularization. Indeed, poor early outcome is expected in
high-risk patients undergoing endovascular revasculariza-
tion4,25 In fact, the minimally invasive nature of this treat-
ment method may easily generate a false sense of safety
toward endovascular treatments in such a fragile patient
population. The present study suggests that identification
of high-risk patients by these risk scores may allow a more
critical decision-making process and better allocation of
resources toward patients who are more likely to benefit
from revascularization. In the future, the need of vascular
surgery will increase significantly as the elderly and diabetic
population increases, and therefore it becomes even more
important to focus on those patients that will gain benefit
from the procedures.
This study has a few limitations. We did not have the
data on dialysis status, a risk factor included into the mod-
ified PIII risk score. Therefore we assigned 4 points to class
V of the CKD classification as it may better categorize those
patients with kidney failure,9 but not yet on dialysis therapy
despite the severity of renal failure. There are also data
suggesting that independent of dialysis status, eGFR pre-
dicts long term survival after lower limb revasculariza-
tion.26
In conclusion, Finnvasc and modified PIII risk scoring
methods predict the long-term outcome of patients under-
going both surgical and endovascular infrainguinal revas-
cularization for CLI. Finnvasc score seems to perform well
also in predicting immediate postoperative outcome. The
accuracy of these risk scores is acceptable. These risk scores
are rather easy to use and could be valuable in the clinical
setting, especially as an aid to decide when not to revascu-
larize.
We would like to thank study nurse Anita Mäkelä for
invaluable help in data collection.
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